CD79A and adult-onset Still disease: Studies of patients with autoimmune or autoinflammatory diseases, including RA, SLE, Sjogren syndrome, Behcet’s disease, polymyalgia rheumatica, connective tissue disease, vasculitis, adult-onset Still’s disease, and sarcoidosis who received the Pfizer vaccination showed lower seroconversion [46,61], anti S1/S2 IgG [36,38,43,61], neutralization [38,43], total IgA [38,43], and anti-RBD IgG [61] than the control group.